Folsom Metal Products recalled 2,700 units of distraction pins on August 21, 2025. The recall affects devices with unvalidated shelf life labeling. Patients and healthcare providers must stop using the product immediately.
Labeling includes shelf life that has not been validated.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Folsom Metal Products, Inc. or your healthcare provider for instructions. Notification method: Letter
The recall includes Frontier Devices, REF: 301.914S1, 14 mm Distraction Pin sold in 5 single packs. The affected units were distributed nationwide in the U.S. from August 1, 2020, to July 30, 2025.
The recall stems from unvalidated shelf life labeling. Use of such devices could lead to ineffective treatment.
There are no reported incidents or injuries associated with this recall at this time. The recall is classified as Class II, indicating a potential for temporary health issues.
Stop using the device immediately. Contact Folsom Metal Products or your healthcare provider for further instructions.
For more information, visit the FDA website or contact Folsom Metal Products directly. Recall notification was sent via letter.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.